Filtered By:
Specialty: Consumer Health News
Drug: Melatonin
Therapy: Stem Cell Therapy
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Stem cell survival after transplantation impacted by melatonin pre-treatment
When melatonin, a hormone secreted by the pineal gland, was used as a pre-treatment for mesenchymal stem cells (MSCs) prior to their transplantation into the brains of laboratory animals to repair damage from stroke, researchers in China found that the stem cells survived longer after transplantation. Previous studies had shown that 80 percent of transplanted MSCs died within 72 hours of transplantation. By contrast, the melatonin pre-treatment "greatly increased" cell survival, said the researchers...
Source: Health News from Medical News Today - July 24, 2013 Category: Consumer Health News Tags: Stroke Source Type: news
